University of Novi Sad, Faculty of Medicine, Hajduk Veljkova 3, 21000 Novi Sad, Serbia.
University of Novi Sad, Faculty of Medicine, Hajduk Veljkova 3, 21000 Novi Sad, Serbia; Vojvodina Institute of Oncology, Center for Diagnostic Imaging, Put dr Goldmana 4, 21204 Sremska Kamenica, Serbia.
J Clin Neurosci. 2019 Oct;68:168-173. doi: 10.1016/j.jocn.2019.07.004. Epub 2019 Jul 16.
The aim of this study was to compare brain volume reduction in patients with Alzheimer's disease (AD) and amnestic mild cognitive impairment (aMCI) with age-related changes in age- and gender-matched healthy individuals. Sixty-six patients were divided in three groups based on medical history, neurological and neurocognitive assessment: 26 patients with AD, 20 patients with aMCI and 20 healthy controls. All participants underwent high-resolution magnetic resonance (MR) imaging on 3 T unit. MR volumetry of cerebral cortex, white matter and lateral ventricles volumes, as well as volumes of subcortical nuclei (hippocampus, amygdala, thalamus) was performed. Global cerebral and grey matter volumes were lower in AD patients compared to aMCI (p = 0.023 and p = 0.001, respectively) and controls (p < 0.001 and p < 0.001, respectively). Volume of lateral ventricles was significantly higher in AD patients compared to controls (right p = 0.007, left p = 0.007). Volumes of thalamus were lower in AD patients (right p < 0.001, left p < 0.001), and in aMCI patients (right p = 0.004, left p = 0.015), compared to controls. Hippocampal volume was lower in AD patients compared to both aMCI patients (right p = 0.047, left p = 0.003) and controls (right p < 0.001, left p < 0.001). In aMCI patients, hippocampal volume was lower than in controls (right p = 0.004, left p = 0.007). Volumes of amygdala were lower in AD patients compared to controls (righ p = 0.003, left p = 0.001). Our results show that thalamic volume loss could be an early sign associated with poorercognitiveperformance in aMCI, preceeding the atrophy of amygdala, global grey and white matter volume loss, and cerebrospinal fluid spaces dilatation.
本研究旨在比较阿尔茨海默病(AD)和遗忘型轻度认知障碍(aMCI)患者的脑体积减少与年龄匹配的健康个体的年龄相关变化。根据病史、神经和神经认知评估,66 名患者分为三组:26 名 AD 患者、20 名 aMCI 患者和 20 名健康对照者。所有参与者均在 3T 磁共振成像仪上进行高分辨率磁共振成像(MR)检查。对大脑皮质、白质和侧脑室体积以及皮质下核(海马体、杏仁核、丘脑)体积进行了磁共振体积测量。与 aMCI(p=0.023 和 p=0.001)和对照组(p<0.001 和 p<0.001)相比,AD 患者的大脑整体和灰质体积更低。与对照组相比,AD 患者的侧脑室体积明显更高(右侧 p=0.007,左侧 p=0.007)。与对照组相比,AD 患者的丘脑体积(右侧 p<0.001,左侧 p<0.001)和 aMCI 患者(右侧 p=0.004,左侧 p=0.015)的丘脑体积更低。与 aMCI 患者(右侧 p=0.047,左侧 p=0.003)和对照组(右侧 p<0.001,左侧 p<0.001)相比,AD 患者的海马体体积更小。与对照组相比,aMCI 患者的海马体体积更小(右侧 p=0.004,左侧 p=0.007)。与对照组相比,AD 患者的杏仁核体积更小(右侧 p=0.003,左侧 p=0.001)。我们的结果表明,丘脑体积减少可能是 aMCI 患者认知功能下降的早期迹象,早于杏仁核、整体灰质和白质体积减少以及脑脊液空间扩张。